| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $3.1M | -14.6% |
| SG&A Expense | $3.4M | -35.6% |
| Operating Income | -$6.4M | -160.9% |
| Pre-tax Income | -$6.0M | -90.7% |
| Income Tax | $0 | — |
| Net Income | -$6.0M | -90.7% |
| EPS (Basic) | -$0.49 | +41.7% |
| EPS (Diluted) | -$0.49 | +41.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | +4210.8% |
| Current Assets | $5.3M | +77.1% |
| Total Assets | $5.3M | +77.1% |
| Current Liabilities | $17.2M | -37.1% |
| Long-term Debt | $1.0M | — |
| Total Liabilities | $17.2M | -37.1% |
| Stockholders' Equity | -$11.9M | +51.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | -34.2% |
| Investing Cash Flow | $1K | -97.4% |
| Financing Cash Flow | $11.0M | +219.9% |